Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001533613-12-000002
Filing Date
2012-07-11
Accepted
2012-07-11 13:19:28
Documents
1
Period of Report
2012-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5144
  Complete submission text file 0001533613-12-000002.txt   6821
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET WORCESTER MA 01605
Business Address
SCHWARTZ MARK W. (Reporting) CIK: 0001422882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 12957506